These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2369814)

  • 1. Quinolones. An overview.
    Neu HC
    Diagn Microbiol Infect Dis; 1990; 13(2):195-6. PubMed ID: 2369814
    [No Abstract]   [Full Text] [Related]  

  • 2. New quinolones in clinical practice.
    Gould IM
    Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10419336
    [No Abstract]   [Full Text] [Related]  

  • 3. New quinolones: their role in clinical practice.
    Masterton RG
    Hosp Med; 1999 Feb; 60(2):82-3. PubMed ID: 10320835
    [No Abstract]   [Full Text] [Related]  

  • 4. Should quinolones be used in the treatment of bacterial infections in neutropenic patients?
    Piddock LJ; Dalhoff A
    J Antimicrob Chemother; 1993 Nov; 32(5):771-4. PubMed ID: 8125842
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in antibacterial therapy: cephalosporins and quinolones.
    Rodriguez WJ; Wiedermann BL
    Adv Pediatr Infect Dis; 1989; 4():183-210. PubMed ID: 2645901
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglycosides, vancomycin, and quinolones.
    McGowan JP
    Cancer Invest; 1998; 16(7):528-37. PubMed ID: 9774959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quinolones. Gyrase inhibitors].
    Höffler D
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract]   [Full Text] [Related]  

  • 8. The quinolones and renal infection.
    Ronald A
    Drugs; 1999; 58 Suppl 2():96-8. PubMed ID: 10553715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New quinolones: similarities and differences].
    Levi GC
    AMB Rev Assoc Med Bras; 1989; 35(5):202-6. PubMed ID: 2486418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New quinolones].
    Bello Dronda S
    Arch Bronconeumol; 1999 May; 35 Suppl 3():70-6. PubMed ID: 10410229
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of the fluoroquinolones.
    Scully BE
    Urology; 1990 Jan; 35(1 Suppl):8-10. PubMed ID: 2404373
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of the quinolones.
    Andriole VT
    Drugs; 1999; 58 Suppl 2():1-5. PubMed ID: 10553697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tosufloxacin tosilate].
    Shimada K
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?
    Thomson KS
    J Antimicrob Chemother; 2000 Jun; 45(6):719-23. PubMed ID: 10837422
    [No Abstract]   [Full Text] [Related]  

  • 15. [New quinolones for the treatment of community-acquired pneumonia--pro].
    Zimmerli S
    Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the pharmacodynamic properties of quinolones.
    Wiedemann B; Rustige-Wiedemann C; Kratz B
    Drugs; 1995; 49 Suppl 2():269-71. PubMed ID: 8549328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quinolones in pediatrics?].
    Krcméry V
    Cesk Pediatr; 1991 Jan; 46(1):57-8. PubMed ID: 1884424
    [No Abstract]   [Full Text] [Related]  

  • 18. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoroquinolones: 2nd generation quinolones].
    Taurand S
    Soins; 1991 Feb; (545):I-II. PubMed ID: 2024184
    [No Abstract]   [Full Text] [Related]  

  • 20. [A. Classification of antibiotics. 4/12--The quinolones].
    Medjoub M; Mandy B; Woronoff-Lemsi MC
    Soins; 2002 Oct; (669):51-2. PubMed ID: 12432686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.